Anke Kretz-Rommel - Concepedia

Author

Anke Kretz-Rommel

Alexion Pharmaceuticals (United States)

Also Known As

A KRETZROMMEL, A Kretz-Rommel, A. Kretz-Rommel, A. Kretz-rommel, A. Kretzrommel, Anke Kretz-Rommel, Kretz-Rommel, Anke

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Alexion Pharmaceuticals (United States)Scripps Research Institute Radboud University Nijmegen École Polytechnique Fédérale de Lausanne Radboud University Medical Center

About

Anke Kretz-Rommel is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	923
2	Cell Biology	9	9	622
3	Allergy	5	5	163
4	Health Sciences	1	1	103
5	Biochemistry	1	1	103

Anke Kretz-Rommel

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari, The Journal of Immunology ImmunologyImmune RegulationNew ApproachesImmunoeditingImmunologic Mechanism	2007	176
Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation John R. McWhirter, Anke Kretz-Rommel, Alan Saven, Proceedings of the National Academy of Sciences Key RoleCombinatorial LibrariesImmunologyImmune RegulationImmunologic Mechanism	2006	153
Selective Protein Adduct Formation of Diclofenac Glucuronide Is Critically Dependent on the Rat Canalicular Conjugate Export Pump (Mrp2) Sven Seitz, Anke Kretz-Rommel, Ronald P.J. Oude Elferink, Chemical Research in Toxicology Molecular PharmacologyHepatologyBiochemistryConjugate Export PumpMedicine	1998	103
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200 Amara C. Siva, Haibei Xin, Fenghua Qin, Cancer Immunology Immunotherapy Immunosuppressive Molecule Cd200Cancer ImmunosurveillanceImmunologyImmune RegulationImmune Modulation	2007	101
Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari, The Journal of Immunology	2008	89
In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari, Journal of Immunotherapy Vivo TargetingHuman Immune SystemImmunologyImmunoeditingImmunotherapeutics	2007	83
Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus. Anke Kretz-Rommel, Steven R. Duncan, Robert L. Rubin Journal of Clinical Investigation Drug-induced LupusT-regulatory CellImmunologyPathologyImmunotherapy	1997	83
Disruption of positive selection of thymocytes causes autoimmunity Anke Kretz-Rommel, Robert L. Rubin Nature Medicine Autoimmune DiseaseLymphocyte DevelopmentImmunologyAutoimmunitySelf-tolerance	2000	82
Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct. Anke Kretz-Rommel, Urs A. Boelsterli Drug Metabolism and Disposition	1994	77
Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis. Anke Kretz-Rommel, Urs A. Boelsterli Molecular Pharmacology	1994	61

Page 1